AB Science: 5.0 ME capital increase

(CercleFinance.com) - AB Science today announced a capital increase of 5.
0 million euros through the issue of 5,368,725 new ordinary shares to which share subscription warrants are attached.

This capital increase has been subscribed by qualified European investors.

Following the capital increase (excluding the exercise of warrants), the Company's share capital will amount to €645,894.28, and will be made up of 64,589,428 shares with a par value of €0.01 each (all share classes included).

Alain Moussy, Chairman and CEO of AB Science, commented: "The AB Science teams are delighted with this fund-raising, subscribed to by both historical and new shareholders, which demonstrates our confidence in the quality of our company's pipeline assets and the success of future milestones. This fundraising is primarily intended to finance the phase 2 clinical development of the microtubule program (AB8939).


Copyright (c) 2024 CercleFinance.com. All rights reserved.